Literature DB >> 17077189

Studies on the physiological functions of the melanocortin system.

Roger D Cone1.   

Abstract

The melanocortin system refers to a set of hormonal, neuropeptidergic, and paracrine signaling pathways that are defined by components that include the five G protein-coupled melanocortin receptors; peptide agonists derived from the proopiomelanocortin preprohormone precursor; and the endogenous antagonists, agouti and agouti-related protein. This signaling system regulates a remarkably diverse array of physiological functions including pigmentation, adrenocortical steroidogenesis, energy homeostasis, natriuresis, erectile responses, energy homeostasis, and exocrine gland secretion. There are many complex and unique aspects of melanocortin signaling, such as the existence of endogenous antagonists, the agouti proteins, that act at three of the five melanocortin receptors. However, there is an aspect of melanocortin signaling that has facilitated highly reductionist approaches aimed at understanding the physiological functions of each receptor and peptide: in contrast to many peptides, the melanocortin agonists and antagonists are expressed in a limited number of very discrete locations. Similarly, the melanocortin receptors are also expressed in a limited number of discrete locations where they tend to be involved in rather circumscribed physiological functions. This review examines my laboratory's participation in the cloning of the melanocortin receptors and characterization of their physiological roles.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17077189     DOI: 10.1210/er.2006-0034

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  206 in total

Review 1.  The renaissance of corticotropin therapy in proteinuric nephropathies.

Authors:  Rujun Gong
Journal:  Nat Rev Nephrol       Date:  2011-12-06       Impact factor: 28.314

2.  Regulation of G protein-coupled receptor signaling: specific dominant-negative effects of melanocortin 2 receptor accessory protein 2.

Authors:  Julien A Sebag; Patricia M Hinkle
Journal:  Sci Signal       Date:  2010-04-06       Impact factor: 8.192

3.  Functional melanocortin-2 receptors are expressed by mouse aorta-derived mesenchymal progenitor cells.

Authors:  Jodi F Evans; Anne Fernando; Louis Ragolia
Journal:  Mol Cell Endocrinol       Date:  2012-01-27       Impact factor: 4.102

4.  Approaches to the rational design of selective melanocortin receptor antagonists.

Authors:  Victor J Hruby; Minying Cai; Joel Nyberg; Dhanasekaran Muthu
Journal:  Expert Opin Drug Discov       Date:  2011-03-24       Impact factor: 6.098

5.  β-Endorphin antagonizes the effects of α-MSH on food intake and body weight.

Authors:  Roxanne Dutia; Kana Meece; Shveta Dighe; Andrea J Kim; Sharon L Wardlaw
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

Review 6.  Developmental specification of metabolic circuitry.

Authors:  Amanda E Elson; Richard B Simerly
Journal:  Front Neuroendocrinol       Date:  2015-09-25       Impact factor: 8.606

7.  Loss of autophagy in pro-opiomelanocortin neurons perturbs axon growth and causes metabolic dysregulation.

Authors:  Bérengère Coupé; Yuko Ishii; Marcelo O Dietrich; Masaaki Komatsu; Tamas L Horvath; Sebastien G Bouret
Journal:  Cell Metab       Date:  2012-01-26       Impact factor: 27.287

Review 8.  Targeting protein-protein interfaces using macrocyclic peptides.

Authors:  Meng Gao; Kui Cheng; Hang Yin
Journal:  Biopolymers       Date:  2015-07       Impact factor: 2.505

9.  Melanocortin-4 receptors expressed by cholinergic neurons regulate energy balance and glucose homeostasis.

Authors:  Jari Rossi; Nina Balthasar; David Olson; Michael Scott; Eric Berglund; Charlotte E Lee; Michelle J Choi; Danielle Lauzon; Bradford B Lowell; Joel K Elmquist
Journal:  Cell Metab       Date:  2011-02-02       Impact factor: 27.287

Review 10.  Design of cyclized selective melanotropins.

Authors:  Minying Cai; Victor J Hruby
Journal:  Biopolymers       Date:  2016-11       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.